The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health-related quality of life (HrQoL) of first-line treatments in metastatic renal cell carcinoma (mRCC): A network meta-analysis.
 
Oluseyi Abidoye
No Relationships to Disclose
 
Syed Arsalan Ahmed Naqvi
No Relationships to Disclose
 
Kunwer Sufyan Faisal
No Relationships to Disclose
 
Manal Imran
No Relationships to Disclose
 
Kaneez Zahra Rubab Khakwani
No Relationships to Disclose
 
Ammad Raina
No Relationships to Disclose
 
Nikita Tripathi
No Relationships to Disclose
 
Haidar Abdul-Muhsin
No Relationships to Disclose
 
Brian Addis Costello
Speakers' Bureau - Clinical Care Options/NCCN (Inst)
Research Funding - GlaxoSmithKline/Novartis (Inst)
 
Parminder Singh
Honoraria - Curio Science; Medpage/ASCO
Consulting or Advisory Role - AVEO; Bayer; EMD Serono; ImmunityBio; Janssen Oncology; Seattle Genetics/Astellas (Inst)
Research Funding - EMD Serono (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen
 
Alan Haruo Bryce
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; Astellas Pharma; AstraZeneca; Bayer; Bayer; Bayer; Castle Biosciences; Horizon CME; Janssen; Janssen Oncology; Lilly; Myovant Sciences; Myovant Sciences; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Research to Practice; Research to Practice; Verity Pharmaceuticals; Verity Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Clovis Oncology (Inst); Pfizer; Pfizer (Inst); Phosplatin Therapeutics (Inst)
 
Irbaz Bin Riaz
No Relationships to Disclose